Please enable Javascript
nmHSPC
Advertisement
Latest News
Read More
Advertisement
Prostate Cancer Knowledge Hubs
Curated clinical content on prostate cancer types, therapies, and technologies
Conference Coverage
Predictors of Renal Function Improvement After Partial Nephrectomy
Jonathan Afari, MD
Localized Renal Cell Carcinoma
|
April 24, 2024
Dr. Afari elaborates on the factors he identified that contribute to renal function improvement post-partial nephrectomy.
CheckMate 274: OS Outcomes for Patients With MIBC
Matthew Galsky, MD
Muscle Invasive Urothelial Carcinoma
|
April 18, 2024
Dr. Galsky shares the first OS data update on the CheckMate 274 trial, which he gave at the 2024 EAU Congress.
Utilizing miRNA as a Liquid Biomarker for Malignancy of Small Testicular Masses
Julian Chavarriaga, MD
Testicular, Penile, and Rare Malignancies
|
April 12, 2024
Dr. Julian Chavarriaga describes his study on using miRNA as a liquid biomarker to detect malignancy in testicular masses.
Radical Prostatectomy vs Radiation Therapy: Comparing Prostate Cancer-Specific Mortality in cN1 Patients
Marco Finati, MD
Prostate Cancer
|
April 9, 2024
Dr. Finati discusses what the future has in store for further investigation utilizing larger patient databases.
Endoscopic vs Surgical Treatment for Low-Grade Bladder Cancer
Guy Verhovsky, MD
Urothelial Carcinoma
|
April 11, 2024
Drs. Grasso and Verhovsky discuss the potential of endoscopic treatment with surveillance for patients with bladder cancer.
BCG-Unresponsive Bladder Cancer: Rechallenging With Rescue BCG
Amanda Myers, MD
Non-Muscle Invasive Urothelial Carcinoma
|
April 9, 2024
Dr. Myers and colleagues challenge the current paradigm of discouraging additional BCG therapy for "unresponsive" NMIBC.
View Full Conference Coverage
Advertisement
Advertisement
Trending
Metabolites in Urine Samples Taken Before and Following Transurethral Resection of Bladder Tumor
Patrick Daly
Advanced Urothelial Carcinoma
|
September 20, 2022
Metabolites were shown to have “the highest potential for differences between urine levels in healthy and BC patients."
Read More
Investigating the Associations Between Smoking and Genetic Variants of Bladder Cancer
Patrick Daly
Advanced Urothelial Carcinoma
|
September 20, 2022
Smoking increased risk of urothelial carcinoma “more than expected” in patients with certain genetic risk factors.
Read More
Liquid Biopsy Biomarkers for Predicting Post-Radical Cystectomy Recurrence in Bladder Cancers
Patrick Daly
Advanced Urothelial Carcinoma
|
September 20, 2022
Researchers developed a model to predict bladder cancer recurrence by combining microRNA with a pathological factor.
Read More